PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The Lancet: WHO's new End TB Strategy

2015-03-24
(Press-News.org) On May 19, 2014, the 67th World Health Assembly (WHA) adopted WHO's "Global strategy and targets for tuberculosis prevention, care and control after 2015". This post-2015 global tuberculosis strategy, labelled the End TB Strategy, was shaped during the past 2 years. A wide range of stakeholders--from ministries of health and national tuberculosis programmes to technical and scientific institutions, financial and development partners, civil society and health activists, non-governmental organisations, and the private sector--contributed to its development. The strategy has a vision of making the world free of tuberculosis, with zero deaths, disease, and suffering due to the disease. In this Viewpoint, Dr Mukund Uplekar from the World Health Organization, and colleagues, outline how achievements in TB control over the past two decades can provide the basis for further progress, and how ending the tuberculosis epidemic is an important health and development goal, achievable in the foreseeable future. This goal can be realised over the next two decades, the authors assert, through optimizing implementation of current tools and approaches, addressing social determinants of TB through universal health coverage and social protection, and investing in research and development adequately to secure and employ new tools of elimination.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: A systematic review and meta-analysis

2015-03-24
Microbiological confirmation of childhood tuberculosis is rare because of the difficulty of collection of specimens, low sensitivity of smear microscopy, and poor access to culture. This study, led by Dr Anne Detjen, from the International Union Against Tuberculosis and Lung Disease, aimed to establish summary estimates for sensitivity and specificity of the Xpert MTB/RIF assay compared with microscopy in the diagnosis of pulmonary tuberculosis in children. The researchers found that compared with microscopy, Xpert offers better sensitivity for the diagnosis of pulmonary ...

News from Annals of Internal Medicine March 24, 2015

2015-03-23
1. Task Force finds insufficient evidence to recommend routine screening for thyroid dysfunction The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to recommend for or against screening for thyroid dysfunction in nonpregnant, asymptomatic adults. The recommendations are published in Annals of Internal Medicine. Thyroid gland disorders are among the most common endocrine conditions evaluated and treated by clinicians and may be asymptomatic. If left untreated, thyroid dysfunction could lead to fractures, cancer, or cardiovascular ...

Archeologists discover Maya 'melting pot'

Archeologists discover Maya melting pot
2015-03-23
Archaeologists working in Guatemala have unearthed new information about the Maya civilization's transition from a mobile, hunter-gatherer lifestyle to a sedentary way of life. Led by University of Arizona archaeologists Takeshi Inomata and Daniela Triadan, the team's excavations of the ancient Maya lowlands site of Ceibal suggest that as the society transitioned from a heavy reliance on foraging to farming, mobile communities and settled groups co-existed and may have come together to collaborate on construction projects and participate in public ceremonies. The findings, ...

Supercomputers give universities a competitive edge, researchers find

2015-03-23
CLEMSON, S.C. -- Researchers have long believed that supercomputers give universities a competitive edge in scientific research, but now they have some hard data showing it's true. A Clemson University team found that universities with locally available supercomputers were more efficient in producing research in critical fields than universities that lacked supercomputers. A supercomputer that can do 551 trillion calculations per second is housed at Clemson's Information Technology Center. A supercomputer that can do 551 trillion calculations per second is housed at ...

Smoking in front of your kids may increase their risk of heart disease as adults

2015-03-23
DALLAS, March 23, 2015 -- Kids exposed to their parents' smoking may have a higher risk of developing heart disease in adulthood than those whose parents didn't smoke, according to research in the American Heart Association journal Circulation. The study's results add to the growing evidence that exposure to smoking from parents has a lasting effect on children's cardiovascular health in adulthood. Researchers tracked participants in the Cardiovascular Risk in Young Finns Study, which included childhood exposure to parental smoking in 1980 and 1983. They collected carotid ...

Detecting cancer cells in blood can give an early warning of treatment failure

2015-03-23
A blood test that measures the number of cells shed from prostate tumours into the bloodstream can act as an early warning sign that treatment is not working, a major new study shows. Researchers showed that measuring the numbers of circulating tumour cells in the blood predicted which men were benefitting least from a prostate cancer drug after as little as 12 weeks of treatment. They hope their work will allow doctors to switch patients to alternative treatments earlier than is currently possible, if these results are confirmed by further studies. The research could ...

Insulin resistance linked to a human gene variant

2015-03-23
Insulin resistance is a risk factor for developing both type 2 diabetes and cardiovascular disease. Almost one third of the U.S. population has some degree of insulin resistance, though it is undiagnosed in many of these individuals. Obesity is associated with reduced insulin sensitivity and the development of insulin resistance. However, recent large-scale genetic studies have indicated that insulin resistance is heritable. A new study in the Journal of Clinical Investigation identifies a gene that is strongly associated with the presence of many features of insulin resistance. ...

Metabolic compensation underlies drug resistance in glioblastoma

2015-03-23
Gliobststoma (GBM) is a highly aggressive brain tumor that is resistant to many conventional cancer therapies. The kinase mTOR induces pathways that are aberrantly activated in GBM. However, mTOR inhibitors have not shown much promise for treating GBM. A new study in the Journal of Clinical Investigation indicates that mTOR inhibitor resistance in GBM is likely the result of compensatory glutamine metabolism. Kazuhiro Tanaka and colleagues at Kobe University determined that glutaminase and glutamine levels increase in GBM cells and xenografts in response to mTOR inhibition. ...

Greater wealth equals better health for most Canadian moms and their newborns

2015-03-23
TORONTO, March 23, 2015 -- Across all income levels, Canadian moms in better socioeconomic standing have better health outcomes than moms in lower socioeconomic brackets. The same relationship between socioeconomic position and health outcomes holds true for these moms' newborn babies, according to a new study. A team of researchers placed 68,705 Canadian new moms and their babies along a socioeconomic spectrum by using factors about the moms such as education, whether she was living in poverty and the income of the neighbourhood she lives in. The researchers compared ...

How to get smarter on pills for seniors

2015-03-23
(PHILADELPHIA) - Open the medicine cabinet of a senior and you're likely to find scores of pill bottles. Physicians are often unaware of all the medications a patient is taking, which can result in unnecessary additional prescriptions, non-prescription medications and potential drug-drug interactions that cause unexpected adverse effects. When a cancer diagnosis is thrown into the mix, the drug-drug interactions can become even more complex. A new study evaluates the currently available screening tools for determining if and when seniors with cancer are taking too many ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] The Lancet: WHO's new End TB Strategy